MediSapiens, Helsinki, Finland, a developer and provider of genomic, biomedical, and healthcare data solutions, recently launched Genius, a genomics data management and querying solution that combines population-level scalability, ultra-high performance, and cost-efficiency. The Cloud-based solution enables researchers to work with massive genomic datasets in real-time while maintaining low operating costs.
“Initiatives such as FinnGen, UK Biobank, 100,000 Genomes England, and the Million Veterans Program are producing genomic data on a population scale,” says Sami Kilpinen, PhD, CEO of MediSapiens. “Current solutions on the market cannot provide instantaneous results in queries made across datasets of this magnitude with high cost-efficiency. We are extremely happy to bring to the market a solution that will enable researchers and healthcare professionals around the world to work with population-scale genomic resources in real time without the need to invest heavily in IT infrastructure.”
With a longstanding background in genomics and experience in the use of genomic resources in both industry and healthcare, MediSapiens overcame the substantial challenges inherent in coping with the amount and complexity of the genomic data now produced globally. One of the primary bottlenecks was enabling researchers and genomic medicine professionals to ask questions over datasets of population scale and receive answers to those questions in a manner of seconds or subseconds, instead of hours, days, or weeks.
“Making real-time queries across datasets in the magnitude of tens of thousands of genomes has been possible already with a bearable cost level,” says Henrik Edgren, chief scientific officer at MediSapiens. “However, moving to millions of genomes has so far meant an unbearably high operating cost.
“We believe that combining these data with rich clinical and phenotypic data and being able to work on the data in real time will benefit the global life science and healthcare community, with the ability to work with population-scale genomics and make discoveries that are possible only with currently available and future data,” adds Edgren.”
To learn more, visit MediSapiens.
